OncoTherapy Science, Inc.TSE 4564

オンコセラピー・サイエンス株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
—
FY ending Mar 2026
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥14.4M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 中村 祐輔 12,511,000 3.26% — —
2 楽天証券株式会社共有口 9,155,500 2.39% — —
3 特定有価証券信託受託者株式会社SMBC信託銀行 7,300,000 1.90% — —
4 中鶴 修一 5,850,000 1.52% — —
5 野村證券株式会社
Asset-management company of 野村 浩子
3,781,200 0.99% — —
6 仲榮眞 正雄 3,000,100 0.78% — —
7 古川 洋一 2,943,000 0.77% — —
8 後藤 知近 2,850,000 0.74% — —
9 手柴 智行 2,553,000 0.67% — —
10 荒川 博文 2,487,400 0.65% — —

Officers' holdings and pay

NameTitleSharesValuePay
嶋田 順一 President & Representative Director — — —
加藤 肇夫 Chairman of the Board — — —
朴 在賢 Director — — —
三木 義男 Director — — —
小峰 雄一 Director — — —
山根 由香 Audit & Supervisory Board Member 50,000 — —
高木 美也子 Audit & Supervisory Board Member 31,000 — —
田島 照久 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 — ¥-2.77 — — 383,643,700
FY ending Mar 2025 — ¥-3.12 — — 271,643,700
FY ending Mar 2024 — ¥-6.05 — — 217,643,700
FY ending Mar 2023 — ¥-5.81 — — 192,643,700
Source: annual securities reports on EDINET. Values are estimates. Methodology